YOLFTbeta
68

Ever Fortune.AI Co. Ltd.

6841 · TWO · Healthcare / Health Information Services

50.00TWD+1.75 (+3.63%)

Price History

Full chart

Market Stats

Previous Close48.25
Open48.65
Day Range48.65 – 50.40
52-Week Range51.00 – 73.95
Volume123.51K
Market Cap5.34B
P/E (TTM)81.88
Forward P/E0.00
EPS0.69
Dividend Yield1.77%
Beta0.39
50-Day Avg54.02
200-Day Avg60.36

About

Ever Fortune.AI Co., Ltd., an cloud-based biomedical platform, provides medical artificial intelligence (AI) solutions and services in China. The company offers medical AI solutions, such as oncology radiotherapy, emergency radiology, computer assisted detection platform for bone scintigraphy, cardio suite SPECT myocardial perfusion agile workflows; and cloud medical, genetic testing AI analysis, smart health check-up scheduling, haircare AI cloud, and underwriting claims medical image recognition platform. It also provides Biotech and Beauty solutions including renexo miracle skin essence, hair revitalizing essence. Ever Fortune.AI Co., Ltd. was founded in 1998 and is based in Taichung, Taiwan. Ever Fortune.AI Co., Ltd. operates as a subsidiary of An Ji Biomedical Corporation.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEODr. Ti-Hao Wang
  • Employees0
  • HeadquartersNo.360, Jingmao Rd, Taichung, Taiwan, 406040, Taiwan
  • Websitehttps://www.everfortuneai.com.tw

Leadership

  • Dr. Ti-Hao WangCTO and Director of Research & Development
  • Dr. Yu-Cheng LiManager
  • En-De LiaoDirector of Marketing & Business
  • Donald LinChief Information Security Officer - Division of Platform & Business

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-3.49M38.24M53.90M93.98M337.52M378.81M
Growth (%)--+996.76%+40.94%+74.35%+259.13%+12.23%
Cost of Revenue-482.00K7.78M14.99M47.36M129.71M153.88M
Gross Profit-3.00M30.47M38.91M46.62M207.81M224.93M
Gross Margin-86.18%79.66%72.19%49.61%61.57%59.38%
Operating Expense-70.67M98.20M-97.72M91.69M177.27M186.37M
Operating Income-50.00M-67.67M-67.74M136.64M-45.07M30.54M38.56M
Operating Margin--1940.64%-177.12%253.49%-47.95%9.05%10.18%
EBITDA-50.00M-57.13M-54.95M154.73M-16.92M77.97M148.50M
EBITDA Margin--1638.34%-143.68%287.05%-18.00%23.10%39.20%
Net Income--54.15M-54.20M136.48M-42.04M30.31M83.35M
Net Income Margin--1552.88%-141.73%253.19%-44.73%8.98%22.00%
R&D-47.92M76.02M67.93M80.17M48.28M64.58M
R&D as % of Total Revenue-1374.19%198.76%126.02%85.30%14.30%17.05%
Interest Expense-17.00K19.00K63.00K71.00K125.00K169.00K
Interest Expense % of Total Revenue-0.49%0.05%0.12%0.08%0.04%0.04%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-1.61B1.55B1.68B2.09B2.09B2.12B
Total Liabilities-29.43M38.97M33.72M88.04M148.47M110.74M
Total Equity-1.58B1.51B1.65B1.93B1.87B1.68B
Cash-106.77M21.36M22.16M230.67M81.75M537.93M
Total Debt-2.93M3.15M2.98M2.56M--
Net Debt--103.84M-18.22M-19.17M-228.11M--

Cash Flow

Currency: TWD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-39.19M-41.92M-60.43M-27.60M62.51M46.77M
Financing Cash Flow1.02B-16.52M-2.98M380.25M--
Capital Expenditure7.76M31.22M7.78M18.96M49.54M76.94M
Free Cash Flow-46.95M-73.14M-68.21M-46.56M12.98M-30.18M
Dividends Paid---194.11M96.39M95.57M
FCF to OCF119.80%174.49%112.88%168.68%20.76%-64.52%
Dividend Paid to FCF----416.90%742.81%-316.72%

Earnings

Report DateAug 14, 2023Nov 13, 2023May 10, 2024May 13, 2025Aug 13, 2025Nov 11, 2025Mar 14, 2026
EPS Estimate-0.15-0.09-0.040.060.020.14
EPS Actual-0.01-0.460.010.180.150.480.08
Surprise93.33%-411.11%-350.00%150.00%2300.00%-42.86%
TimingPre-marketAfter-hoursPre-marketAfter-hoursPre-market-Pre-market

Key Statistics & Ratios

Market Cap5.34B
Enterprise Value3.97B
Trailing P/E81.88
Forward P/E0.00
Price / Sales13.95
Price / Book3.19
EPS0.69
Book Value16.76
Revenue (TTM)382.65M
Gross Profit (TTM)252.72M
EBITDA66.23M
Profit Margin16.79%
Operating Margin20.41%
Return on Equity3.48%
Return on Assets1.27%
Shares Outstanding94.46M
Shares Float63.72M
Beta0.39
Dividend Yield1.77%
Dividend Rate1.00
Payout Ratio1.79%

Dividends

20261×
1.00May 19, 2026
20251×
1.02May 21, 2025
20241×
1.00Jun 7, 2024
20231×
2.00May 22, 2023